Investment
Features
FeesSafety
Academy
More
Pluang+

Compare YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF (QDTY) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETFTrade
Roivant Sciences Ltd. Common SharesTrade

Price performance (Past 24H)

Key statistics

YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF vs Roivant Sciences Ltd. Common Shares — how do they compare? YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF trades at $39.54 (market cap $28.69M), while Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 861.6× YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF for 60 Days and Roivant Sciences Ltd. Common Shares for 0 Days on average.

QDTYROIV
Market Cap
$28.69M$24.72B
Volume
22,4906,279,442
Sector
Income / Options OverlayHealth
52-Week High
$46.71$41.81
52-Week Low
$36.57$16.04
Typical Hold Time
60 Days0 Days
Enterprise Value
—$20.99B

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

QDTY
100% Buy0% Sell
Avg holding period · 60 Days
ROIV
100% Buy0% Sell
Avg holding period · 0 Days

About YieldMax Nasdaq 100 0DTE Covered Call Strategy ETF

QDTY is an actively managed ETF that employs a synthetic covered call strategy on the Nasdaq-100 Index using zero-days-to-expiration (0DTE) options. It aims to generate high weekly income by selling daily call options, providing limited participation in the index's upside while remaining fully exposed to its downside risk.

Read more on QDTY →

About Roivant Sciences Ltd. Common Shares

Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.

Read more on ROIV →